Bober Sharon L, Falk Sandy J
Department of Supportive Oncology.
Adult Survivorship Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Clin Obstet Gynecol. 2025 Mar 1;68(1):51-59. doi: 10.1097/GRF.0000000000000918. Epub 2025 Jan 23.
As the majority of female cancer survivors can now expect to live long lives beyond cancer diagnosis and treatment, there is a growing need to address the significant late effects of treatment. Unfortunately, sexual health remains a primary concern that often goes unaddressed among female cancer survivors. Sexual dysfunction is one of the most common and distressing effects of treatment. Management of issues related to sexual health and sexual function depends upon the type of malignancy, stage and other tumor characteristics, treatment, and the history, concerns, and goals of the individual patient.
由于现在大多数女性癌症幸存者有望在癌症诊断和治疗后长期存活，因此越来越有必要解决治疗带来的重大晚期影响。不幸的是，性健康仍然是女性癌症幸存者中经常被忽视的主要问题。性功能障碍是治疗最常见、最令人苦恼的影响之一。与性健康和性功能相关问题的管理取决于恶性肿瘤的类型、阶段和其他肿瘤特征、治疗方法以及个体患者的病史、关注点和目标。
